Clinical practice guideline–supported administration of monoclonal antibody therapy for high-risk patients with COVID-19: Experience of a quaternary care centre
CPG-supported mAb administration for management of COVID-19 in high-risk patients was associated with favourable clinical outcomes and may be a useful model to guide future therapies.
Authors
- Keely Hammond (ORCID: https://orcid.org/0000-0003-1767-2025)
- François Bourdeau
- Makeda Semret (ORCID: https://orcid.org/0000-0003-3875-4847)
- Donald C. Vinh (ORCID: https://orcid.org/0000-0003-1347-7767)
- Marina Klein
Institutions
- Canadian Institutes of Health Research (CA)
- McGill University Health Centre (CA)
- McGill University (CA)
Publication Details
- Journal
- Journal of the Association of Medical Microbiology and Infectious Disease Canada
- Published
- 2024-09-03
- DOI
- https://doi.org/10.3138/jammi-2024-0005
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00